Vance Rubenstein has over 15 years of experience in US Market Access, currently leading CVRM Market Access Strategy teams at AstraZeneca. They focus on strategies that engage with PBMs, health plans, and health systems, contributing to notable product launches including FARXIGA and BRILINTA. Vance’s efforts have resulted in significant business impacts through talent attraction, skill development, and fostering high engagement. They hold a Bachelor of Science from Penn State University and an MBA from Saint Joseph's University. Previously, Vance worked as a financial auditor at Ernst & Young and held various roles at AstraZeneca throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices